PSS Board Director, Kimimitchi Obata (Global Sales & Marketing Division, Executive Officer) has passed away because of gastric cancer to Sunday, November 16, 2014. Along with this, he has resigned as a director with the same date. We thank Dr Obata and his family for close association during his lifetime, and provide our heartfelt appreciation. […]
Sydney, Australia –- Genetic Signatures Ltd has launched its prospectus offering institutional and retail investors the opportunity to invest in the exciting growing global molecular diagnostics market prior to the Company’s listing on the Australian Stock Exchange on 23 December 2014. Molecular diagnostics (MDx) is a modern technique increasingly used by hospitals and pathology labs […]
Protagen AG today announced that it has entered into a long-term collaboration agreement with QIAGEN targeting the development of novel protein-based companion diagnostics for autoimmune disorders. Under the terms of the agreement, QIAGEN will gain access to the proprietary SeroTag® technology platform of Protagen, which enables the discovery and validation of novel protein-based marker panels. […]
SOUTH SAN FRANCISCO, Calif. – Sequenta, Inc., a biotechnology company developing clinical diagnostics based on immune cell receptor genes, today announced that the company has entered into an agreement with Illumina, Inc. (NASDAQ: ILMN). The purpose of the agreement is to commercialize an in vitro diagnostic (IVD) kit that will enable clinical laboratories to utilize […]
Basel — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® Strep A test for the detection of group A streptococcus bacterial (Strep A) DNA in throat swab specimens. The cobas Strep A test runs on the cobas Liat System, a […]
SUNNYVALE, Calif. — Cepheid (NASDAQ: CPHD) today announced that it has been awarded a grant of up to $3.3 million co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation to develop Xpert® Ebola, a rapid test that could be run on Cepheid’s installed base of more than 3,500 GeneXpert® […]
Singapore -– Vela Diagnostics announced today that it has completed the listing of its Next-Generation Sequencing (NGS) system with the U.S. Food and Drug Administration (FDA) for clinical use as a class II device. The Vela Diagnostics NGS System comprises the Sentosa® ST401 instruments which provide an automated solution for template preparation and enrichments, the […]
CORALVILLE, IA -– Integrated DNA Technologies (IDT) has acquired a license from ELITech Group (Bothell, WA) to manufacture and supply MGB Eclipse® Probes for use as a component in human in vitro diagnostic tests. As a result of improved knowledge and understanding of the human genome, quantitative real-time PCR (qPCR) has become an increasingly important […]
Coralville, IA — Integrated DNA Technologies (IDT) has acquired a license from ELITech Group (Bothell, WA) to manufacture and supply MGB Eclipse® Probes for use as a component in human in vitro diagnostic tests. As a result of improved knowledge and understanding of the human genome, quantitative real-time PCR (qPCR) has become an increasingly important […]
Cleveland, OH -– GenomOncology announced today that the Ohio State University, College of Medicine, Department Of Pathology will use the company’s GO Clinical WorkbenchTM to enable clinical reporting of mutations detected from next generation sequencing (NGS). “Cancer is a complex disease, with tremendous diversity in pathology and genetics,” commented Weiqiang John Zhao, MD, PhD, FCAP, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
